Skip to content

Alvotech

US · ALVO #2709 by market cap Listed 2020
4.12 -0.17 -3.96%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Alvotech

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Founded
2013
CEO
Mr. Vilhelm Robert Wessman
Employees
1,460
Headquarters
Luxembourg, Luxembourg, Luxembourg
Fiscal year end
12-31
Website
alvotech.com

Company profile

Exchange
US
Symbol
ALVO
Market-cap rank
#2709
Listing date
2020-11-09
Market cap
1.47B
Float cap
498.39M
Shares out
356.82M
Float shares
120.97M

Sectors & themes

Drug Manufacturers - Specialty & Generic Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Alvotech discussion 0 comments

Add a comment